MIDDLETOWN, Ohio — A week after Ohio Sen. J.D. Vance became Donald Trump’s running mate,…
-
-
One woman was putting her toddler to bed in Baltimore when her phone pinged. Another…
-
Democratic leaders on Monday laid out a new process for selecting a presidential nominee to…
-
A business executive and philanthropist has pledged $30 million to launch a first-of-its-kind center pushing…
-
The increasing likelihood that Vice President Harris, the White House’s chief defender of abortion rights,…
-
Good morning and welcome to this week’s Flight Path. We saw a lot of weakness…
-
Friday was a bad day for CrowdStrike Holdings (CRWD) as a bug was pushed out…
-
In this edition of StockCharts TV‘s The Final Bar, Dave breaks down today’s upside recovery day for…
-
Investing
Radiopharm Theranostics Receives FDA IND Approval for Phase 2b Imaging Trial in Brain Metastases
Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative…
-
Brightstar Resources Limited (ASX: BTR) (Brightstar or the Company) is pleased to announce the second…